Patient-reported outcome (PRO) assessment in clinical trials: A systematic review of guidance for trial protocol writers

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Calvert, Melanie ^a,b   Kyte, Derek ^a   Duffy, Helen ^a   Gheorghe, Adrian ^c   Mercieca Bebber, Rebecca ^d   Ives, Jonathan ^a   Draper, Heather ^a,b   Brundage, Michael ^e   Blazeby, Jane ^f   King, Madeleine ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MRC Midland Hub for Trials Methodology Research   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

^e QUEEN S UNIVERSITY   (Canada)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; CLINICAL STUDY; HUMAN; MEDICAL DOCUMENTATION; OUTCOME ASSESSMENT; PATIENT REPORTED OUTCOME ASSESSMENT; PUBLICATION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SYSTEMATIC REVIEW; CLINICAL TRIAL (TOPIC); META ANALYSIS; METHODOLOGY; SELF REPORT; STANDARDS;

CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT OUTCOME ASSESSMENT; RESEARCH DESIGN; SELF REPORT;

EID: 84908179392     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110216     Document Type: Review

References (70)

1. FDA (2009) Patient Reported Outcome Measures: Use in Medical Product Development to Support Labelling Claims. Guidance for Industry.
2. Basch E (2010) The missing voice of patients in drug-safety reporting. N Engl J Med 362: 865-869.
3. Calvert M, Brundage M, Jacobsen PB, Schunemann HJ, Efficace F (2013) The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice. Health Qual Life Outcomes 11: 184.
4. Kyte D, Ives J, Draper H, Keeley T, Calvert M (2013) Inconsistencies in quality of life data collection in clinical trials: A potential source of bias? Interviews with research nurses and trialists. PloS one 8.
5. Fielding S, Maclennan G, Cook JA, Ramsay CR (2008) A review of RCTs in four medical journals to assess the use of imputation to overcome missing data in quality of life outcomes. Trials 9: 51.
6. Chan, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, et al. (2013) SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Annals of Internal Medicine 158: 200-207.
7. The Lancet (2010) Strengthening the credibility of clinical research. The Lancet 375: 1225.
8. Chan A, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, et al. (2013) SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 346: 1-42.
9. Kyte DG, Draper H, Ives J, Liles C, Gheorghe A, et al. (2013) Patient Reported Outcomes (PROs) in Clinical Trials: Is 'In-Trial'Guidance Lacking? A Systematic Review. PloS one 8: e60684.
10. Brundage M, Bass B, Davidson J, Queenan J, Bezjak A, et al. (2011) Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers. Quality of Life Research 20: 653-664.
11. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339.
12. University of Birmingham Patient Reported Outcomes Research Group Study Protocol Available: http://www.birmingham.ac.uk/Documents/college-mds/groups/Patient-Reported-Outcomes/Study-Protocol-Evaluation-of-Patient-Reported-Outcomes-%28PROs%29-in-Clinical-Trials-Systematic-Review-of-Trial-Protocols.pdfAccessed 2014 September 5.
13. iPROSPECT (2006) iPROSPECT Search Engine User Behaviour Study. Available: http://district4.extension.ifas.ufl.edu/Tech/TechPubs/WhitePaper-2006-SearchEngineUserBehavior.pdf Accessed 2014 September 22.
14. Oxford University Press (2014) Oxford Dictionaries.Available: http://www.oxforddictionaries.com/Accessed 2014 September 22.
15. Moinpour CM, Feigl P, Metch B, Hayden KA, Meyskens FL, et al. (1989) Quality of life end points in cancer clinical trials: review and recommendations. Journal of the National Cancer Institute 81: 485-496.
16. Schron E, Shumaker S (1991) The integration of health quality of life in clinical research: experiences from cardiovascular clinical trials. Progress in cardiovascular nursing 7: 21-28.
17. Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson BD (1992) Quality-oflife assessment in cancer treatment protocols: research issues in protocol development. Journal of the National Cancer Institute 84: 575-579.
18. Osoba D (1992) The quality of life committee of the clinical trials group of the National Cancer Institute of Canada: organization and functions. Quality of Life Research 1: 211-218.
19. Gotay C, Korn E, McCabe M, Moore T, Cheson B (1992) Building quality of life assessment into cancer treatment studies. Oncology (Williston Park, NY) 6: 25-28; discussion 30-22, 37.
20. Nayfield S, Ganz P, Moinpour C, Cella D, Hailey B (1992) Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Quality of Life Research 1: 203-210.
21. Sadura A, Pater J, Osoba D, Levine M, Palmer M, et al. (1992) Quality-of-Life Assessment: Patient Compliance With Questionaire Completion. Journal of the National Cancer institute 84: 1023-1026.
22. Hayden K, Moinpour C, Metch B, Feigl P, O'Bryan R, et al. (1993) Pitfalls in quality-of-life assessment: lessons from a Southwest Oncology Group breast cancer clinical trial; pp. 1415-1419.
23. Cella D, Wiklund I, Shumaker S, Aaronson N (1993) Integrating health-related quality of life into cross-national clinical trials. Quality of life research 2: 433- 440.
24. Spilker (1996) Quality of Life & Pharmacoeconomics in Clinical Trials: Applying quality of life principles in International cancer clinical trials. Chapter 72 Bernhard J et al al.
25. Molin C, Arrigo C (1995) Clinical trials and quality of life assessment: The nurses' viewpoint. European Journal of Cancer 31: S8-S10.
26. Fayers P, Hopwood P, Harvey A, et al, Girling D, et al. (1997) Quality of life assessment in clinical trials-guidelines and a checklist for protocol writers: the UK medical research council experience. European Journal of Cancer 33: 20- 28.
27. Kiebert G (1997) Quality of life as an outcome in EORTC clinical trials. European Journal of Cancer 33: S31-S34.
28. Bernhard J, Cella DF, Coates AS, Fallowfield L, Ganz PA, et al. (1998) Missing quality of life data in cancer clinical trials: serious problems and challenges. Statistics in medicine 17: 517-532.
29. Bernhard J, Peterson H, Coates A, Gusset H, Isley M, et al. (1998) Quality of Life Assessment in International Breast Cancer Study Group (IBCSG) Trials: Practical Issues and Factors Associated with Missing Data. Statistics in Medicine 17: 587-601.
30. Osoba D, Zee B (1998) Completion rates in health-related quality-of-life assessment: Approach of the National Cancer Institute of Canada Clinical Trials Group. Statistics in medicine 17: 603-612.
31. Simes RJ, Greatorex V, Gebski V (1998) Practical approaches to minimize problems with missing quality of life data. Statistics in medicine 17: 725-737.
32. Moinpour CM, Lovato LC (1998) Ensuring the quality of quality of life data: the Southwest Oncology Group experience. Statistics in medicine 17: 641-651.
33. Brooks MM, Jenkins LS, Schron EB, Steinberg JS, Cross JA, et al. (1998) Quality of Life at Baseline: Is Assessment After Randomization Valid? Medical care 36: 1515-1519.
34. Leidy NK, Revicki DA, Geneste B (1999) Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value in Health 2: 113-127.
35. Osoba D (1999) What has been learned from measuring health-related quality of life in clinical oncology. European journal of cancer 35: 1565-1570.
36. De Haes J, Curran D, Young T, Bottomley A, Flechtner H, et al. (2000) Quality of life evaluation in oncological clinical trials-the EORTC model. European Journal of Cancer 36: 821-825.
37. Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, et al. (2000) Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Quality of Life Research 9: 887- 900.
38. Bottomley A (2001) Developing Clinical Trial Protocols for Quality of Life. Applied Clinical Trials 10: 40-44.
39. Hakamies-Blomqvist L, Luoma ML, Sjostrom J, Pluzanska A, Sjodin M, et al. (2001) Timing of quality of life (QoL) assessments as a source of error in oncological trials. Journal of advanced nursing 35: 709-716.
40. Santanello NC, Baker D, Cappelleri JC, Copley-Merriman K, DeMarinis R, et al. (2002) Regulatory Issues for Health-Related Quality of Life-PHRMA Health Outcomes Committee Workshop, 1999. Value in Health 5: 14-25.
41. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N (2002) Patientreported outcomes: the example of health-related quality of life-a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal 36: 209- 238.
42. EORTC (2002) Guidelines for Assessing Quality of Life in EORTC Clinical Trials.Available: http://groups.eortc.be/qol/sites/default/files/archives/clinical-trials-guidelines-qol.pdf Accessed 2014 22nd Sept.
43. Movsas B (2003) Quality of life in oncology trials: A clinical guide. Elsevier. 235- 247.
44. Calvert M, Freemantle N (2004) Use of health-related quality of life in prescribing research. Part 2: methodological considerations for the assessment of health-related quality of life in clinical trials. Journal of clinical pharmacy and therapeutics 29: 85-94.
45. Wiklund I (2004) Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life. Fundamental & clinical pharmacology 18: 351-363.
46. Buchanan DR, O'Mara AM, Kelaghan JW, Minasian LM (2005) Quality-of-life assessment in the symptom management trials of the National Cancer Institutesupported Community Clinical Oncology Program. Journal of clinical oncology 23: 591-598.
47. Fayers PM, Hays RD (2005) Assessing quality of life in clinical trials: methods and practice: Oxford University Press.
48. Lipscomb J (2004) Outcomes Assessment in Cancer: Use of health related quality of life measures by industry and regulatory agencies in evaluating oncology therapies. Chapter 27 Revicki DA p.
49. Avery K, Blazeby JM (2006) Quality of life assessment in surgical oncology trials. World journal of surgery 30: 1163-1172.
50. TROG (2007) Assessing Health Related Quality of Life in Cancer Patients: A research clinicians guide. TROG Policy and Procedures.
51. Ganz PA, Gotay CC (2007) Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions. Journal of Clinical Oncology 25: 5063-5069.
52. Lipscomb J, Reeve BB, Clauser SB, Abrams JS, Bruner DW, et al. (2007) Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. Journal of Clinical Oncology 25: 5133-5140.
53. Land SR, Ritter MW, Costantino JP, Julian TB, Cronin WM, et al. (2007) Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches. Journal of Clinical Oncology 25: 5113-5120.
54. Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, et al. (2007) Patient- Reported Outcomes to Support Medical Product Labeling Claims: FDA Perspective. Value in Health 10: S125-S137.
55. Sloan JA, Dueck AC, Erickson PA, Guess H, Revicki DA, et al. (2007) Analysis and Interpretation of Results Based on Patient-Reported Outcomes. Value in Health 10: S106-S115.
56. Revicki DA, Erickson PA, Sloan JA, Dueck A, Guess H, et al. (2007) Interpreting and reporting results based on patient-reported outcomes. Value in Health 10: S116-S124.
57. Fayers P, Machin D (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes: John Wiley & Sons.
58. Fairclough DL (2012) Design and analysis of quality of life studies in clinical trials: CRC press.
59. Hao Y (2010) Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges.
60. NCIC CTG Quality of Life Committee Orientation Handbook.(2014).
61. Basch (2011) Recommendations for Incororating Patient-Reported Outcomes into the Design of Clinical Trials in Adult Oncology. Effective Guidance Document 1.0.
62. Efficace F, Taphoorn M (2012) Methodological issues in designing and reporting health-related quality of life in cancer clinical trials: the challenge of brain cancer studies. Journal of neuro-oncology 108: 221-226.
63. Jensen RE, Moinpour CM, Fairclough DL (2012) Assessing health-related quality of life in cancer trials. Clinical Investigation 2: 563-577.
64. Novik et al. European Hematology Association:Scientific Working Group Guidelines:Patient-Reported Outcomes in Hematology: Chapter 2.
65. Macefield RC, Avery KN, Blazeby JM (2013) Integration of clinical and patientreported outcomes in surgical oncology. Br J Surg 100: 28-37.
66. King M University of Sydney, Psycho-oncology Cooperative Research Group (PoCoG) (2011) Quality of Life Protocol Checklist.
67. Kyte D, Draper H, Calvert M (2013) Patient-reported outcome alerts: ethical and logistical considerations in clinical trials. JAMA 310: 1229-1230.
68. Curran D, Molenberghs G, Fayers PM, Machin D (1998) Incomplete quality of life data in randomized trials: missing forms. Stat Med 17: 697-709.
69. Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, et al. (2013) Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. Jama 309: 814-822.
70. Dolan P, Shaw R, Tsuchiya A, Williams A (2005) QALY maximisation and people's preferences: A methodological review of the literature. Health Econ 14: 197-208.